Results 21 to 30 of about 1,418,988 (256)

Use of Proton Pump Inhibitors in Hungary: Mixed-Method Study to Reveal Scale and Characteristics

Frontiers in Pharmacology, 2020
BackgroundDue to their efficacy and tolerability, utilization of proton pump inhibitors (PPI) has significantly increased worldwide. Parallel to the clinical benefits, potential long-term side effects have been observed, which, along with increasing ...
Mária Matuz, Ria Benkő, Zsófia Engi, Krisztina Schváb, Péter Doró, Réka Viola, Mária Szabó, Gyöngyvér Soós   +7 more
doaj   +1 more source

Therapeutic effect of proton pump inhibitor (Omeprazole) on homogenous leukoplakia with clinico-fractal analysis: A pilot study

Journal of Indian Academy of Oral Medicine and Radiology, 2020
Background: Oral leukoplakia is a white patch or plaque that cannot be characterized clinically or pathologically as any other disease and is not associated with any physical or chemical causative agent except the use of tobacco.
Nivethitha Nagarajan, S Jayachandran
doaj   +1 more source

Proton Pump Inhibitor-Related Gastric Mucosal Changes

Gut and Liver, 2021
Proton pump inhibitors (PPIs) are used worldwide to treat of acid-related disorders such as peptic ulcer and gastroesophageal reflux disease and to prevent gastroduodenal injuries due to nonsteroidal anti-inflammatory drugs.
Gwang Ha Kim
doaj   +1 more source

Efficacy of Helicobacter pylori eradication therapies: a single centre observational study

BMC Gastroenterology, 2001
Background Many Helicobacter pylori eradication regimens have been described. There are little data reporting their efficacy or integration in routine clinical practice. The overall results of eradication therapy in a cohort of patients are described and
Beales Ian LP
doaj   +1 more source

Is proton pump inhibitor therapy always needed in the elderly?

, 2015
Is proton pump inhibitor therapy always needed in the ...
Carmelo Scarpignato (1), Meschi, T, Giuseppe Lippi (5), Riccò, M, Maria Piera Panozzo (3), Massimo Rugge (7), Antico, A, Panozzo, MP, Massella, A, Gianluca Baldassarre (2), Rugge, M, Tiziana Meschi (1), Baldassarre, G, LIPPI, Giuseppe, Antonio Antico (3), Alberta Caleffi (5), Goni, E, Caleffi, A, Matteo Riccò (4), Elisabetta Goni (1), Di Mario, F, Marilisa Franceschi (2), Francesco Di Mario, Antonio Nouvenne (6), Arianna Massella (2), Franceschi, M, Nouvenne, A, Scarpignato, C.   +27 more
core   +1 more source

First Proton Pump Inhibitor Prescription Filled After Hospital Discharge.

, 2012
First Proton Pump Inhibitor Prescription Filled After Hospital Discharge.
Geoffrey M. Anderson (155717), Lauren Lapointe-Shaw (155700), Paula A. Rochon (86025), Chaim M. Bell (155723), Alice Newman (155711), Ava John-Baptiste (155714), Hadas D. Fischer (155706)   +6 more
core   +1 more source

Proton pump inhibitors overuse - consequences among patients

Journal of Education, Health and Sport, 2019
Introduction Omeprazole was first proton pump inhibitor (PPI) approved for use by patients. Thirty years have passed since then. Due to their effectiveness, low price and safety proton pump inhibitors have become one of the most frequently prescribed ...
Patrycja Kmiotek, Andrzej Materniak, Barbara Skrzydło-Radomańska   +2 more
doaj   +3 more sources

Eradication of Helicobacter Pylori

Медицинский совет, 2015
General idea. The article is a review of data on Helicobacter pylori resistance to antibiotics, the impact of CYP2C19 polymorphism on the metabolism of proton pump inhibitors, and recent findings on the effectiveness of eradication.
V. V. Tsukanov, E. V. Kasparov, A. V. Vasyutin, Y. L. Tonkikh   +3 more
doaj   +1 more source

Transcriptome analysis of proton pump inhibitor–responsive esophageal eosinophilia reveals proton pump inhibitor–reversible allergic inflammation [PDF]

, 2015
Esophageal eosinophilia can be proton pump inhibitor (PPI) resistant or responsive, representing two entities known as eosinophilic esophagitis (EoE) and PPI-responsive esophageal eosinophilia (PPI-REE), respectively.
Rothenberg, Marc E, Moawad, Fouad J, Aceves, Seema S, Wen, Ting, Furuta, Glenn T, Dellon, Evan S, Dellon, Evan S., Moawad, Fouad J., Aceves, Seema S., Rothenberg, Marc E., Furuta, Glenn T.   +10 more
core   +1 more source

Soft motions encoded by the fold and mediated by conserved hinge sites drive V‐ATPase allosteric machinery and autoinhibition

FEBS Letters, EarlyView.
Vacuolar H+‐ATPase (V‐ATPase) is a multisubunit rotary proton pump that acidifies intracellular compartments. Using elastic network models, we identified conserved hinge residues that govern its large‐scale functional motions. We show that intrinsically encoded ‘soft modes’ drive critical functional transitions, including rotary catalysis and ...
Diksha Parwana, Xiaowei Bogetti, Stuti Sharma, Ivet Bahar   +3 more
wiley   +1 more source